Actively Recruiting

Age: 45Years +
All Genders
NCT06555289

Outcomes of Clareon PanOptix Pro in Patients With Prior Myopic Refractive Surgery

Led by Juliette Eye Institute Research Center · Updated on 2025-12-12

40

Participants Needed

1

Research Sites

96 weeks

Total Duration

On this page

Sponsors

J

Juliette Eye Institute Research Center

Lead Sponsor

S

Sengi

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study is a Single center, single arm, prospective, observational study of clinical outcomes following bilateral cataract surgery and Clareon PanOptix Pro implantation. Subjects will be assessed preoperatively, and at 1 and 3 months postoperatively. Clinical evaluations will include administration of the QUVID and IOLSAT questionnaires, manifest refraction, topography, as well as measurement of visual acuities at distance, intermediate, and near.

CONDITIONS

Official Title

Outcomes of Clareon PanOptix Pro in Patients With Prior Myopic Refractive Surgery

Who Can Participate

Age: 45Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 45 years or older with confirmed age-related cataracts eligible for bilateral cataract surgery
  • Prior binocular myopic photorefractive keratectomy (PRK) or myopic LASIK
  • Regular corneal astigmatism less than or equal to 0.6 diopters and candidates for PanOptix Pro spherical IOL
  • Patients with regular corneal astigmatism who are candidates for PanOptix Pro toric IOL T3
  • Postoperative visual potential of monocular 20/25 or better as judged by the surgeon
Not Eligible

You will not qualify if you...

  • Any ocular condition that could impair postoperative visual acuity including corneal abnormalities, moderate to severe dry eyes not relieved by treatment, eye inflammation, retinal pathology, or glaucoma
  • Pregnancy or lactation
  • Any ocular surgery other than corneal myopic refractive surgery (LASIK or PRK)
  • Physical or intellectual disabilities affecting fixation (e.g., Down's Syndrome, Parkinson's Disease)
  • Apple Kappa/chord mu greater than or equal to 0.6
  • Higher order corneal aberrations above specified thresholds at 4mm pupil diameter
  • Requirement for a limbal relaxing incision
  • Investigator discretion based on medical evidence indicating unsuitability for the trial

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Juliette Eye Institute Research Center

Albuquerque, New Mexico, United States, 87113

Actively Recruiting

Loading map...

Research Team

Z

Zoe Baker, OD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Outcomes of Clareon PanOptix Pro in Patients With Prior Myopic Refractive Surgery | DecenTrialz